UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

                       FEBRUARY 5, 2007 (FEBRUARY 2, 2007)
                DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED)

                         COMPETITIVE TECHNOLOGIES, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

                                    DELAWARE
                                    --------
                 (STATE OR OTHER JURISDICTION OF INCORPORATION)

                           1-8696          36-2664428
                           ------          ----------
             (COMMISSION FILE NUMBER)     (IRS EMPLOYER IDENTIFICATION NO.)


           777 COMMERCE DRIVE, SUITE 100, FAIRFIELD, CONNECTICUT 06825
           -----------------------------------------------------------
               (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)(ZIP CODE)

                                 (203) 368-6044
                                 --------------
               REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:

                                       N/A
          (FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.02.   DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

      On  February  2, 2007, at the reconvened Annual Meeting of Stockholders of
the  Company, the existing Board of Directors of the Company was replaced by the
shareholders  with  the  following new directors:  John B. Nano, Ben Marcovitch,
William  L.  Reali,  Joel  M.  Evans, MD., Richard D. Hornidge, Jr. and Ralph S.
Torello.  The  final confirmed vote by the Independent Inspectors of Election to
elect  the  forgoing  directors  was  2,893,470  as opposed to 1,549,754 for the
former  management  slate,  a  margin  of  1,343,716  shares  and  a  total  of
approximately  two  to  one  for  those  voting  for  directors.



     In  addition, immediately following the stockholders meeting, the new board
met  and  elected  John  B.  Nano  as  Chairman of the Board of Directors, Chief
Executive  Officer  and  President.

     The  Board  terminated  Donald  J.  Freed  as  Chief  Executive  Officer.

     The newly elected Board appointed William L. Reali as Chairman of the Audit
Committee  with Richard Hornidge and Joel Evans as members.  The Board appointed
Ben Marcovitch as Chairman of the Nominating committee with William L. Reali and
Joel  Evans as members.  The Board appointed Richard Hornidge as chairman of the
Compensation  Committee  with  Ben  Marcovitch  and  Ralph  Torello  as members.

     Information  with  respect to Mr. Nano and the other newly elected officers
and  directors  is  set  forth  below:

     JOHN  B.  NANO, 62, is the newly elected President, Chief Executive Officer
and  Chairman  of  the  Board  of  Directors.  In  January  2006 Mr. Nano became
President  and  Chief  Executive  Officer  of  Articulated Technologies, LLC., a
company  involved  in creating and commercializing patented light emitting diode
technologies  for  global  solid state lighting applications.  He is currently a
member  of their Board of Directors.  Mr. Nano was President and Chief Executive
Officer  of  Competitive Technologies, Inc. from June 2002 until June 2005.  Mr.
Nano  also  served  as  Chief Financial Officer of Competitive Technologies from
August  2003  to  May  2004.  He  has  a  broad  background  in  domestic  and
international  operating  experience with technology-based companies focusing on
life  sciences,  physical sciences, digital technology and electronics. Prior to
joining  CTT  in  2002,  Mr. Nano held various executive leadership positions in
operations,  strategic  planning,  business  development, M&A and finance.  From
2000  to  2001, he served as a Principal reporting to the Chairman of Stonehenge
Network  Holdings, N.V., a global virtual private network provider, with respect
to  certain  operating,  strategic planning and finance functions.  From 1998 to
1999, Mr. Nano served as Executive Vice President and Chief Financial Officer of
ConAgra  Trade Group, Inc., a subsidiary of ConAgra, Inc., an international food
company.  From  1993  to  1998,  he served as Executive Vice President and Chief
Financial  Officer  of Sunkyong America, the American subsidiary of the Sunkyong
Group,  a  Korean conglomerate, and President of an Internet Startup Division of
Sunkyong  America.

     BEN  MARCOVITCH, 72, was elected as a Director of the Company and appointed
as  Chairman  of  the Nominating Committee.  Mr. Marcovitch has over 50 years of
in-depth  experience  in  corporate finance, financial reporting, and compliance
matters.  He  is  a  financial advisor for Columbia-based Inversiones Bettana, a
company  involved  in  fruit  processing for nutriceutical operations. From July
2002  to  October  2003 he was with DDS Technologies Inc. as President and Chief
Executive  Officer,  and  Chairman  of  the  Board.  DDS  develops  biomass,
disaggregation  equipment for the food and beverage industry. From 2000 to 2001,
he  was  a  Director and Chairman of the Board of Findex.com, Inc., a developer,
publisher  and  distributor  of  religious software products for individuals and
organizations.

     From  1998  through  2000,  Mr.  Marcovitch  was Chairman and CEO of Gemini
Capital  Partners,  Ltd.,  a  financial services firm established in the UK. For
several  years  prior  to  that  Mr.  Marcovitch acted as a private investor and
financial  advisor.  He  was  with  Triumph  Investments  Company,  a  portfolio
management  firm,  as  Chairman  and  CEO  from  1994  through  1996.

     From  1986  through  1998,  he  was Chairman and CEO of publicly-traded GNP
Products,  Inc.,  a  manufacturer  and  distributor  of  natural  food  products
throughout  the  US.

     As  Chairman of Belgium Standard Industries, a 27-company conglomerate, Mr.
Marcovitch  developed  and managed capital markets as well as the firm's trading
activities  for  high  growth, high and low technology companies. The investment
portfolio  included Sanitary Refuse Company, one of the largest waste management
companies  in  Canada,  and  a  division  of  Belgium Standard Industries. Other
activities  included acting as CEO of Sogevox, Inc., a peat moss company, and as
CEO  of  Western,  Allebee  Oil  &  Gas,  Inc.



     From  1963  to  1983  Mr. Marcovitch was the CEO and President of Montreal,
Canada-based  Budget  Fuels Inc., a distributor of refined petroleum products in
Eastern  Canada,  and  the  Northeastern  US.  Budget  was  sold  to a major oil
refinery.  Mr.  Marcovitch  began his career in Montreal as Vice President of HY
Grade  Fuels,  responsible  for  coordinating the buying, marketing, service and
distribution  of  fuel  in  Montreal.

     Mr.  Marcovitch  has a Business degree from McGill University. He is active
in  various  business  and  social  organizations.

     WILLIAM  L.  REALI,  64,  was  elected as a Director of the Company and was
appointed  as  Chairman of the Audit Committee.  Mr. Reali is a Certified Public
Accountant  with  the firm of Reali, Giampetro and Scott in Canfield, Ohio.  The
firm  provides  auditing  and  other  related  accounting  and tax services to a
diverse  group  of business clients. Mr. Reali's primary responsibility with the
firm  is  business  consulting,  working  with  large  and  small  national  and
multinational  clients.  He  has worked with distressed companies assisting them
with  cost  reduction,  turn-around  programs  and  re-organization.  Serving as
Chairman  of  various  community associations, Mr. Reali donates a great deal of
time  to  local  organizations.  Mr. Reali received his BA from Youngstown State
University.

     RICHARD  D. HORNIDGE, JR., 60, was elected as a Director of the Company and
appointed  Chairman  of the Compensation Committee.  Mr. Hornidge is a long time
and  respected  stockholder  of  Competitive  Technologies,  and owner of 62,000
shares  of  Competitive  Technologies  common  stock.  Since  February 2005, Mr.
Hornidge  has  been  a  tennis  professional  at  Willows  Racquet Club in North
Andover,  Massachusetts.  From  June  1984  through  June 1989, Mr. Hornidge was
President  of  Travis  Associates,  an  employment  agency.  Mr.  Hornidge was a
program  coordinator  for Raytheon from 1973 through 1984, where he was involved
in  the Patriot Missile test equipment program.  Mr. Hornidge received a BA from
Boston  University.

     JOEL  M.  EVANS,  M.D.,  46, was elected as a Director of the Company.  Dr.
Evans  founded  The  Center  for Women's Health in Stamford, Connecticut in June
1996  and  since  then has been its Director. From November 1996 to present, Dr.
Evans  has been a lecturer and senior faculty member of The Center for Mind Body
Medicine in Washington, D.C. Dr. Evans has been featured in magazines as well as
interviewed  on  television and radio shows across the country.  Dr. Evans is an
Assistant  Clinical  Professor at the Albert Einstein College of Medicine in New
York  City  and  helped  create  a clinical study at Columbia University Medical
Center  for use of the herb, black cohosh, in breast cancer.  From November 2005
to  present,  Dr.  Evans  has been a member of the Scientific Advisory Board for
Metagenics Incorporated, a nutritional supplement manufacturer. Dr. Evans brings
key  nutriceutical  experience  to  the  Company.

     Dr.  Evans  completed  his  undergraduate and medical studies at the Sophie
Davis School of Biomedical Education of the City College of New York and the Mt.
Sinai  School  of  Medicine.  He  fulfilled his residency at the Albert Einstein
College  of  Medicine.

     RALPH  S.  TORELLO,  68,  was  elected  as  a Director of the Company.  Mr.
Torello is an independent financial consultant with over 45 years' experience in
the  financial  and  venture  capital field, advising various companies on their
financial  strategies.  Included  among  the  companies and individuals that Mr.
Torello  has  performed  consulting  services  for  are  Goodnight Audio, a full
service  recording  studio,  Patriot  American  Mortgage,  a commercial and home
mortgage  company,  DDS Technologies, Inc., an organic waste processor, and Coit
Medical,  a  medical  accessory  marketer.

     During  the  eighties  and  nineties  he  handled  personal ventures in oil
exploration,  real  estate  and the development of bio-organic products.  During
the  seventies and eighties, Mr. Torello was Managing Partner of his own venture
capital  and development firm.  During the sixties, he was Director of Financial
Analysis  for  The  Singer  Company, Assistant to the President of Illinois Tool
Works,  Vice  President  of Laird Industries, and head of Investment Banking for
Bay  Securities  in  San  Francisco.

     Mr.  Torello  received  a BS from Fordham University, and holds an MBA from
Harvard  University.



Employment  Agreement
---------------------

     Effective  February  2,  2007,  the  Company  entered  into  a  three-year
employment  agreement  with  Mr.  John  B.  Nano,  our  Chief Executive Officer.
Pursuant  to  the terms of the agreement, Mr. Nano will receive a minimum annual
base  compensation  of  $350,000,  eligibility to participate in bonus and other
employee  benefit  plans, and the continuation of base compensation and benefits
in  the event of a termination of his employment, subject to certain conditions.

     In  connection  with  his employment agreement, Mr. Nano agreed to withdraw
with  prejudice  the  following  two  lawsuits  which  he  had with the company:

John  Nano  v. Competitive Technologies, Inc., Docket m 3:06-cv-00817 (CFD), now
pending  in  the  United  States  District  Court,  District  of  Connecticut.

Competitive  Technologies,  Inc.  v. John B. Nano, Docket m FST-CV-06-4007624-S,
now  pending  in  the Connecticut Superior Court, Judicial District of Stamford.

     In connection with the first lawsuit, the Company had recently been ordered
to  deposit  $2,500,000 in escrow as a prejudgment remedy on behalf of Mr. Nano.
Mr. Nano has agreed to terminate these lawsuits and enter into releases with the
Company  instead in consideration of a payment of $1,000,000 in damages (from an
estimated  $5,000,000 projected) and payment of his attorneys fees consisting of
$650,000.

ITEM  9.01.  FINANCIAL  STATEMENTS  AND  EXHIBITS

Exhibit 10.1     Employment Agreement between the Company and John B. Nano dated
as  of  February  2,  2007

Exhibit  10.2     Press  Release  dated  February  2,  2007

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                         COMPETITIVE TECHNOLOGIES, INC.
                                  (Registrant)

Dated: February 5, 2007                    By: /s/John B. Nano
                                           -------------------
                              John B. Nano
                              Chairman and Chief Executive Officer